Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased to announce the launch of new social media campaigns via Twitter, Facebook and LinkedIn.
The primary goal of these new campaigns is to provide patients suffering from bladder cancer, their loved ones and the general public with an online resource to better understand the disease state as well as to provide access to up-to-date information on this disease.
Imagin Medical intends to help patients gain control of their journey through education and innovation in the field of bladder cancer.
In addition to educational resources, Imagin Medical will be leveraging these digital channels to keep investors up to date on its corporate progress and company activities. Members of our executive team and scientific advisory board will also regularly contribute thought leadership content.
The Company is run by an experienced Boston-based medical device executive team that has significant surgical endoscopy experience gained over decades of helping define how minimally invasive surgery is performed today.
Jim Hutchens, President & CEO, commented, “Imagin is actively building a digital market awareness ecosystem that will help not only patients, but also keep our investors informed.”
We encourage readers to follow us on Facebook (ImaginMedical), Twitter (@ImaginMedical) and LinkedIn (Imagin Medical) or visit our website at www.imaginmedical.com for further information. – BioSpace